Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability

Adv Exp Med Biol. 1999:469:287-93. doi: 10.1007/978-1-4615-4793-8_42.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aspirin / pharmacology*
  • Capillary Permeability / drug effects*
  • Capillary Permeability / physiology*
  • Cell Movement / drug effects
  • Fatty Alcohols / pharmacology
  • Glycols / pharmacology
  • Hydroxyeicosatetraenoic Acids / chemistry
  • Hydroxyeicosatetraenoic Acids / physiology*
  • Lipoxins*
  • Mice
  • Mice, Inbred BALB C
  • Neutrophils / drug effects*
  • Neutrophils / physiology*
  • Receptors, Leukotriene B4 / antagonists & inhibitors
  • Receptors, Leukotriene B4 / physiology

Substances

  • Fatty Alcohols
  • Glycols
  • Hydroxyeicosatetraenoic Acids
  • Lipoxins
  • Receptors, Leukotriene B4
  • lipoxin A4
  • U 75302
  • lipoxin B4
  • Aspirin